Atlas market file · Equity · Europe
TME Pharma N.V.ALTME
- Last close
- 0.0627
- Change
- +2.79%
- 96-bar range
- 0.0579 – 0.0915
- As of
- 30 Jul 2026
TME Pharma N.V. is a healthcare or life-sciences issuer listed as ALTME on EURONEXT. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- EURONEXT symbol identity
- Chart rail
- TradingView
- File state
- Public profile
ALTME
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
â–® up candle â–® down candle
Weekly outlook: the last 104 weekly closes (-58.27% over the window).
Source rail: Yahoo Finance chart API (ALTME.PA). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for ALTME. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
ALTME public profile
Healthcare or life-sciences issuer. TME Pharma N.V. is connected to current market context, cited company sources and its retained research file.
TME Pharma N.V. trades as ALTME on EURONEXT. TME Pharma N.V. (ALTME) has a latest verified close of 0.0627, up 2.79%, dated 30 Jul 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files ALTME under Healthcare & Medicine Stocks for browsing.
Market Wit preview
ALTME is the shorthand; TME Pharma N.V. is the harder part. TME Pharma N.V. is listed on EURONEXT in Europe with TradingView symbol EURONEXT:ALTME and public listing evidence. Markets love shorthand because it fits on a phone and moves quickly. Businesses are less cooperative. They need customers, demand, cash, management decisions, supply chains, products, and enough patience to survive their own PowerPoint habits. Until fresh operating data arrives, ALTME is best read through customers, margins, capital and disclosure rather than the daily price, because the business is the part that survives after the quote has moved on (source: public profile, https://atlas.freedomcore.io/stocks/ALTME/).
Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for ALTME.
What changed for TME Pharma N.V. today
TME Pharma N.V. (ALTME) is tracked as a listed company on EURONEXT. The public profile anchors the symbol identity, region, chart route, and research-only context for the Europe market before any daily source layer is added.
ALTME is handled first as a equity file: identity, listing route, source trail, chart context, and the current limits of the public evidence set.
The deeper daily research layer expands only when fresh evidence changes the file. Until then, this page keeps the public profile, chart route, risks, catalysts, and research-only framing explicit instead of manufacturing movement for its own sake.
Sources & evidence · 1 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
ALTME technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-27. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on ALTME
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep ALTME research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
ALTME FAQ
What is TME Pharma N.V. (ALTME)?TME Pharma N.V. (ALTME) has a latest verified close of 0.0627, up 2.79%, dated 30 Jul 2026. Use this page to check the price chart, company context, source-backed...
TME Pharma N.V. (ALTME) has a latest verified close of 0.0627, up 2.79%, dated 30 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for ALTME?TME Pharma N.V. (ALTME) has a latest verified close of 0.0627, up 2.79%, dated 30 Jul 2026. It brings the latest available chart, company context, cited sources, risks...
TME Pharma N.V. (ALTME) has a latest verified close of 0.0627, up 2.79%, dated 30 Jul 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files ALTME under Healthcare & Medicine Stocks for browsing.
How often is the ALTME page updated?The ALTME public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The ALTME public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for ALTME?The ALTME file starts with EURONEXT symbol identity and TradingView EURONEXT:ALTME. The page separates verified market context from company evidence and shows open...
The ALTME file starts with EURONEXT symbol identity and TradingView EURONEXT:ALTME. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on ALTME?Yes. The workstation can open ALTME, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open ALTME, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this ALTME page investment advice?No. The ALTME page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The ALTME page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-07-30. Browse FreedomCore Atlas research notes →